Dergiler / Medical Science and Discovery / 2016 / Cilt: 3 Sayı: 5

A case of Zellweger syndrome accompanied by hypertrophic cardiomyopathy

A case of zellweger syndrome accompanied by hypertrophic cardiomyopathy

Sayfa
242–4
Yayın Tarihi
2016-05-15
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Here we present a newborn with Zellweger syndrome and hypertrophic cardiomyopathy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Peroxisomal biogenesis disorders are a group of genetically and clinically heterogenous disorders which affect very-long chain fatty acid metabolism.
📊
Temel Bulgular & Veri:Zellweger syndrome (ZS) is a rare, congenital disorder characterized by multisystem involvement including central nervous system, skeletal system, liver, kidney and eyes, due to absence of peroxisomes in the cells.
💡
Sonuç & Katkı:Here we present a newborn with Zellweger syndrome and hypertrophic cardiomyopathy.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hypertrophic Cardiomyopathy · Zellweger Syndrome · Newborn

Abstract

Peroxisomal biogenesis disorders are a group of genetically and clinically heterogenous disorders which affect very-long chain fatty acid metabolism. Zellweger syndrome (ZS) is a rare, congenital disorder characterized by multisystem involvement including central nervous system, skeletal system, liver, kidney and eyes, due to absence of peroxisomes in the cells. Hypertrophic cardiomyopathy (HCM) is defined as septal or posterior wall thickness that is more than two standard deviations above the mean normal thickness measured by echocardiography. Here we present a newborn with Zellweger syndrome and hypertrophic cardiomyopathy.

🔖

Bu Makaleye Atıf Yap

Kale, Y., Celik, I., Kulali, F., Yilmaz, O., Bas, A., Demirel, N. (2016). A case of Zellweger syndrome accompanied by hypertrophic cardiomyopathy. Medical Science and Discovery, Cilt: 3 Sayı: 5, 242–4. https://ajindex.com/articles/1003081

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Wanders, R. J. A. Metabolic and molecular basis of peroxisomal disorders: a review. Am. J. Med. Genet 2004; 126: 355-75.
  2. Gould SJ, Raymond GV, Valle D. The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Valle D, Sly WS (eds) The metabolic & molecular bases of inherited disease. New York: McGraw-Hill, 2001.p. 3181–217. Ng PC. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993; 68: 330-36.
  3. Ben-Shacher G, Moller JH, Castaneda-Zuniga W, Edwards JE. Signs of membranous subaortic stenosis appearing after correction of persistent common atrioventricular canal. Am J Cardiol 1981; 48: 340-4. Grayer J. Recognition of Zellweger syndrome in infancy. Adv Neonatal Care. 2005; 5: 5-13.
  4. Kelley RI, Datta NS, Dobyns WB, Hajra AK, Moser AB, Noetzel MJ, et al. Neonatal adrenoleukodystrophy: New cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy sydnromes. Am J Med Genet 1986; 23: 869-901.
  5. Badertscher A, Bauersfeld U, Arbenz U, Baumgartner MR, Schinzel A, Balmer C. Cardiomyopathy in newborns and infants: a broad spectrum of aetiologies and poor prognosis. Acta Paediatr 2008; 97: 1523-8.